Publication | Open Access

Early relapse after autologous hematopoietic cell transplantation remains a poor prognostic factor in multiple myeloma but outcomes have improved over time

Hematological MalignancyTransplantationMarrow TransplantationMedicineMalignant Blood DisorderStem Cell TransplantationImmunologyHematologyPathologyMultiple MyelomaBlood TransplantationImmunotherapyOncologyCell TransplantationTumor MicroenvironmentPoor Prognostic Factor